We provide communications and investor relations services to companies specializing in science and enabling technologies: emerging pharmaceuticals & biopharmaceuticals; medical devices; diagnostics; biorenewable energy & industrial biotechnology and health care information technology. Our focus is on the increasing convergence of technology and health care. Our culture is dynamic and entrepreneurial, yet we work with some of the best-known -- and unknown -- names in the life sciences industry.

We know that reaching key stakeholders effectively requires a new approach. We call our approach Intelligent Influence because we understand who and what motivates people to change opinions, attitudes and behavior, and how best to engage them in a conversation that ultimately influences them to change. Whether the goal is to present science compellingly enough to move a physician out of his/her prescribing comfort zone, or to craft the right messaging to generate timely interest in a client investment opportunity, Porter Novelli Life Sciences has strong capabilities to help drive positive change.

With the support of our parent companies, Porter Novelli and Omnicom, Porter Novelli Life Sciences has the unique ability to combine the benefits of an intimate and nimble boutique agency with the global resources of a multinational corporation.

To learn more about our approach to health care communications, investor relations and the services we offer, we invite you to explore this site or contact us directly.